Numerous current clinical investigations are restricted by limited sample sizes, abbreviated follow-up durations, and methodological discrepancies
"It will be a market with fierce competition, but who will be [the leader] is hard to say," she said.
Limitations of Use: SOLIQUA 100/33 contains lixisenatide
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease
Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit
Helps Metabolic Balance: Supports healthier blood sugar regulation, which may reduce spikes and dips that contribute to overeating and low energy